Act 1 of 2023 is now in effect for many Pennsylvanians! The law eliminates all costs associated (including co-pays, deductibles and co-insurance) with screening breast MRI, breast ultrasounds and BRCA-related genetic testing and counseling for individuals at high risk for hereditary cancers who are insured under Pennsylvania law.
Act 1 applies to state-regulated insurance. It does not impact federally regulated insurance including ERISA, Medicare, and Medicaid, and self-insured plans.
Click on our resources below to learn more about who is covered, when coverage begins and what types of questions you may want to ask your insurer or benefits administrator.